Lars Masanneck
Duesseldorf, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Editorial: Digital medicine in psychiatry and neurology-from mobile monitoring to scalable, equitable care.
Journal: Frontiers in psychiatry
Published: July 21, 2026
Exploring serum biomarkers in paediatric psychiatry: the impact of NfL and GFAP.
Journal: Translational psychiatry
Published: July 14, 2026
Neurofilament light chain as a tool for assessing disease activity and treatment response in Multiple Sclerosis
Journal: Fortschritte der Neurologie-Psychiatrie
Published: July 13, 2026
Delivering high-quality multiple sclerosis care in Germany: challenges and regional models.
Journal: Neurological research and practice
Published: July 04, 2026
Digital transformation in multiple sclerosis: Advances in diagnostics, monitoring and patient-centred care
Journal: Fortschritte der Neurologie-Psychiatrie
Published: June 24, 2026
From measurement to biomarker trajectories: platform-agnostic Z score analysis of serum NfL and GFAP in ocrelizumab-treated multiple sclerosis.
Journal: Journal of neurology
Published: March 23, 2026
Evaluating the First CE-Marked LLM-Based Chatbot for Evidence-Based Neurology.
Journal: European journal of neurology
Published: March 14, 2026
Finite depletion, sustained control: can impulse therapy prevent rebound activity in multiple sclerosis?
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: March 13, 2026
Rethinking EDSS-based ambulation assessment in multiple sclerosis using continuous variable monitoring.
Journal: Neurological research and practice
Published: February 24, 2026
Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.
Journal: BMC neurology
Published: February 15, 2026
Brain age gap in multiple sclerosis: associated with disability but independent of serum biomarkers.
Brain age gap in multiple sclerosis: associated with disability but independent of serum biomarkers.
Journal: Therapeutic advances in neurological disorders
Published: January 18, 2026
Last Updated: 09/26/2026